Skip to main content

Table 2 Cause-specific hazard ratio (HR) comparing CRT versus RT for each competing event based on the logrank test

From: Analysis and design of randomised clinical trials involving competing risks endpoints

Variables

O

E

Unadjusted HR (95% CI)

p-value

M : Distant metastasis

    

   RT

38

26.54

0.43 (0.25 - 0.72)

0.002

   CRT

18

29.46

1.00

 

R : Loco-regional recurrence

    

   RT

10

9.19

0.84 (0.34 - 2.07)

0.711

   CRT

9

9.81

1.00

Â